Clinical trial

Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer

NCT00003041

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-07-01

PhasePHASE2

Study timeline

Study start (unknown)1997-07-01Date precision: month

Registry last updated2013-01-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

pyrazoloacridineDRUG

Sponsors & collaborators

Ohio State University Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ColumbusOhio, United States3 LexingtonKentucky, United States1 GreenvilleSouth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003041 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.